Recent Articles from GlobeNewswire

Approximately $263 million of gross equity raised in support of FPUSA

PITTSBURGH, July 23, 2026 (GLOBE NEWSWIRE) -- Eos Energy Enterprises, Inc. (NASDAQ: EOSE) ("Eos" or the “Company”), America’s leading innovator in designing, manufacturing, and providing zinc-based long duration energy storage (LDES) systems sourced and manufactured in the United States, today announced results of its rights offering, which expired at 5:00 p.m. Eastern Time on July 21, 2026 (the “Expiration Date”). Rights that were not exercised by 5:00 p.m. Eastern Time on the Expiration Date have expired and are no longer exercisable.

Research reveals attendees place equal value on learning from exhibitors, peers and the expo floor, challenging traditional event design

Agreement Temporarily Restricts Preferred-to-Common Stock Conversions Below a Defined Price Threshold, Mitigating Potential Near-Term Dilution

County cites enhanced services and customer experience and improved resource efficiencies

WEST PALM BEACH, Fla., July 23, 2026 (GLOBE NEWSWIRE) -- Autonomous Power Corporation dba Powerus, a U.S.-based autonomous systems company building next-generation drone infrastructure for defense and critical infrastructure, today announced, through its wholly owned subsidiary Kaizen Aerospace, Inc., a dedicated agriculture division and two distribution agreements that place its xFoldTM Dragon heavy-lift aircraft with established agricultural operators in Australia and New Zealand.

LOWELL, Mass., July 23, 2026 (GLOBE NEWSWIRE) -- MACOM Technology Solutions Holdings, Inc. (“MACOM”) (Nasdaq: MTSI) plans to announce financial results for its third quarter ended July 3, 2026, before market open on Thursday, August 6, 2026. In conjunction with the release, MACOM will conduct a conference call at 8:30 a.m. Eastern Time on Thursday, August 6, 2026 hosted by Mr. Stephen G. Daly, President and Chief Executive Officer, and Mr. John F. Kober, Senior Vice President and Chief Financial Officer.

Delivers up to 6622MB/s Performance – Turns Massive 12K RAW Video Files, 8K Multi-Cam Sequences, and Monster Photo Libraries Into Effortless Workflows

K25.ai closes Series A investment round, reaching a post-money valuation of US$200 million

CAMBRIDGE, Mass., July 23, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, will host a live webcast and conference call at 8:30 a.m. ET on Thursday, July 30, 2026, to review the company’s second quarter 2026 financial results and provide business updates.

DALLAS, July 23, 2026 (GLOBE NEWSWIRE) -- Cato Supply Inc. today announced its official rebrand to Cato Healthcare Supply, a strategic evolution that better reflects the company's mission. Cato stands for Completely Autonomous Trading Operation—an intelligent procurement platform designed to automate and optimize healthcare sourcing, helping providers strengthen supply chain resilience while protecting critical revenue.

BEDFORD, Mass., July 23, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Thursday, August 6, 2026, to discuss its financial results and provide a business update for the second quarter of 2026.

SAN CLEMENTE, Calif., July 23, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its second quarter 2026 earnings release and conference call.

SYDNEY, July 23, 2026 (GLOBE NEWSWIRE) -- Brazilian Rare Earths Limited (ASX: BRE / OTCQX: BRELY) ('BRE') is pleased to report progress during the quarter ended 30 June 2026. Highlights during and subsequent to the end of the quarter include:

Tarrytown, New York, USA, July 23, 2026 (GLOBE NEWSWIRE) --

Fraudsters are using sophisticated identity schemes, driving larger auto loan losses from fewer incidents

Golfers take control of their environment to extend their play on hot summer days

Recognition highlights Tigunia Spark’s purpose-built approach to helping nonprofits simplify fund accounting, approvals, reporting, and operations inside Microsoft Dynamics 365 Business Central

Kansas City, Mo., July 23, 2026 (GLOBE NEWSWIRE) -- CRB, a leading global provider of engineering, architecture, construction and consulting solutions for the life sciences and food and beverage industries, today announced the appointment of Joe Finsterwald as the company's first Chief Technology Officer (CTO). The role reflects CRB's continued investment in digital innovation, enterprise technology and AI-enabled project delivery.

Conference call scheduled for 4:30 p.m. Eastern Time

New devices combine network synchronization, ultra-low jitter clocking and AccuTime™ software to help simplify time-sensitive network designs

Voluntary NRC readiness review to support 2026 SOLO™ Construction Permit Application and Terra’s 2028 commercialization target

Vancouver, BC, July 23, 2026 (GLOBE NEWSWIRE) -- Skyharbour Resources Ltd. (TSX-V: SYH) (OTCQX: SYHBF) (Frankfurt: SC1P) (“Skyharbour” or the “Company”) is pleased to announce that it has acquired 46 new mineral claims totaling approximately 149,439 hectares through Saskatchewan’s low-cost online staking process. Skyharbour has developed a proprietary, in-house mineral tenure monitoring and staking system that confers a competitive advantage in the acquisition and holding of these claims. These recent acquisitions form ten new or reacquired uranium exploration projects and add to three existing projects within the Company’s extensive portfolio in northern Saskatchewan. Skyharbour’s total portfolio now consists of ownership interests in 682,100 hectares (1.69 million acres) across 44 uranium properties, further strengthening one of the largest uranium project portfolios in Canada’s Athabasca Basin, which is consistently ranked as a top mining jurisdiction by the Fraser Institute.

Partnership Expands Access to Clinically Critical Genetic Testing in Support of Leading Research Programs

Vancouver, BC, July 23, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI” or the “Company”) today announced that its wholly owned digital health platform and marketplace subsidiary, Rocket Doctor Inc., has been selected as one of Canada’s Top 100 AI & Tech Startups for ALL IN 2026, Canada’s largest event dedicated to artificial intelligence and advanced technologies.Selected from more than 330 applicants, Rocket Doctor Inc. was recognized for the strength of its innovation and its contribution to advancing Canada’s artificial intelligence and technology ecosystem. The company will showcase its platform at ALL IN 2026 in Montréal on September 16 and 17.The recognition reflects Rocket Doctor Inc.’s continued advancement of physician-led, AI-enhanced solutions designed to improve healthcare access, reduce administrative burden and support better clinical decision-making. Through its digital health platform and marketplace, proprietary software and intelligent clinical workflows, Rocket Doctor Inc. helps physicians deliver more efficient, connected and accessible care across Canada and the United States.Rocket Doctor Inc.’s platform currently supports more than 350 physicians and has enabled more than 750,000 patient visits across North America. The company continues to expand its work with healthcare systems, governments, pharmacies, medical schools, employers and insurers, while maintaining a strong focus on rural, remote and underserved communities.“We’re honoured to see Rocket Doctor recognized among Canada’s Top 100 AI & Tech Startups,” said Dr. William Cherniak, Co-Founder and Chief Executive Officer of Rocket Doctor Inc. “Our focus has always been on giving physicians better tools, reducing friction in care delivery and helping more patients access the support they need. Artificial intelligence is most valuable when it pairs with physicians to help solve real healthcare challenges. This recognition by ALL IN reflects the work of our entire team, and the real-world impact our platform is already having on improving patient care across North America.”At ALL IN 2026, Rocket Doctor Inc. will demonstrate how its platform supports clinical workflows, intelligent patient intake and triage, care coordination and expanded access to physician-led healthcare. The company will also meet with healthcare leaders, investors, technology partners and policymakers to explore new opportunities for collaboration and growth.ALL IN is Canada’s largest event dedicated to artificial intelligence and advanced technologies, bringing together more than 7,500 participants from over 40 countries, including global technology leaders, investors, researchers, startups and public-sector organizations. Rocket Doctor Inc. will exhibit alongside Canada’s most promising AI companies as part of the Top 100 AI & Tech Startups showcase.About Rocket Doctor AI Inc. Rocket Doctor AI Inc. delivers physician-built, AI-powered solutions designed to make high-quality healthcare accessible throughout the entire patient journey. A cornerstone of the company’s proprietary technology is the Global Library of Medicine (GLM), a clinically validated decision support system developed with input from hundreds of physicians worldwide.Alongside the GLM is Rocket Doctor Inc, and its AI-powered digital health platform and marketplace. Having helped empower over 350 MDs to provide care to more than 750,000 patient visits, our proprietary technology software and systems enable doctors to independently launch and manage their own virtual or hybrid in-person practices - improving efficiency, restoring autonomy to MDs, and expanding patient access to care. By reducing administrative burdens and ensuring greater consistency in care, our technology creates more time for meaningful physician-patient interactions. We are committed to reaching underserved, rural, and remote communities in Canada who often lack access to family doctors and supporting patients on Medicaid and Medicare in the United States. With advanced AI, large language models, and connected medical devices, Rocket Doctor AI is redefining modern healthcare - making it more scalable, equitable, and patient-centered.To learn more about Rocket Doctor AI Inc’s products and services, contact:www.rocketdoctor.ai  or email: info@rocketdoctor.ai FOR ADDITIONAL INFORMATION, CONTACT:Dr. Essam Hamza, CEO, Rocket Doctor AIessam.hamza@rocketdoctor.aiDr. Bill Cherniak, CEO, Rocket Doctor Inc.bill@rocketdoctor.io For media inquiries, contact: media@rocketdoctor.ai Call: +1 (778) 819 8321

SAN DIEGO, July 23, 2026 (GLOBE NEWSWIRE) -- Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS), a Technology Company in the Defense, National Security and Global Markets, announced today that it will publish financial results for the second quarter 2026 after the close of market on Tuesday, August 4th. Management will discuss the Company’s operations and financial results in a conference call beginning at 2:00 p.m. Pacific (5:00 p.m. Eastern).

Agreement formalizes UMeWorld’s previously announced SCO strategy and advances its southern China initiative from technology validation toward commercial deployment

STOUGHTON, Mass., July 23, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading biopharmaceutical company focused on improving the lives of people living with serious and often misunderstood conditions, today announced that it will report second quarter 2026 financial results before the market opens on Thursday August 6, 2026. Following the release of the financials, the Company will host a live conference call and webcast at 8:00 a.m. ET.

Orphan designation provides market exclusivity and development benefits in the European Union as both programs advance in global pivotal clinical trials

WILMINGTON, Del., July 23, 2026 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing IKT-001 for Pulmonary Arterial Hypertension (“PAH”), today announced that the U.S. Food and Drug Administration (“FDA”) has granted Orphan Drug Designation (“ODD”) to its lead product candidate IKT-001, a prodrug of imatinib mesylate, for the treatment of PAH.   

AUSTIN, Texas, July 23, 2026 (GLOBE NEWSWIRE) -- YETI Holdings, Inc. (“YETI”) (NYSE: YETI) today announced that it plans to report its second quarter fiscal year 2026 financial results on Thursday, August 13, 2026, before the market opens. YETI will host a conference call at 8:00 a.m. ET to discuss its financial results.

The expanded partnership gives Workday customers streamlined, native access to OpenSesame's curated learning content across the Workday Talent Suite.

New Agentforce Contact Center implementation helps Compass Working Capital automate financial coaching workflows, save an estimated 6,000 hours annually, and deliver AI-powered voice support 

This support helps expand access to trusted clinical tools and patient resources designed to advance evidence-based pain management education

Appointment formalizes a two-decade relationship, pairing FDH Electronics' global portfolio with CWS' local market expertise.

Partnership pairs Refinity's conversion technology with Zeton's modular fabrication expertise to accelerate the path from demonstration to commercialization

NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- GPGI, Inc. (NYSE: GPGI), a diversified multi-industry platform for companies with great positions in good industries, today announced it will host a conference call on Thursday, August 6, 2026, at 8:00 a.m. Eastern Daylight Time (EDT) to discuss its financial results for the second quarter ended June 30, 2026. GPGI’s earnings results will be reported in a press release prior to the call.

DUBAI, United Arab Emirates, July 23, 2026 (GLOBE NEWSWIRE) -- Upcomers, the proprietary trading evaluation firm, has unveiled Upcomers 2.0, its biggest update since the firm debuted in 2024. The new chapter pairs a refreshed website and a bold visual identity with a broader platform: futures, an AI coach, and an upgraded dashboard.

New open-source tools enable AI agents to keep books, file agentic expense reports, work with trusted financial data, and share their work with human finance teams

CHINO, Calif., July 23, 2026 (GLOBE NEWSWIRE) -- Karat Packaging Inc. (“Karat” or the “Company”) (Nasdaq: KRT), a specialty distributor and manufacturer of environmentally friendly, disposable foodservice products and related items, today announced it will release its 2026 second quarter after market close on Thursday, August 6, 2026. The Company will host an investor conference call on the same day.

FORT MYERS, Fla., July 23, 2026 (GLOBE NEWSWIRE) -- American Oncology Network (AON), one of the nation’s fastest-growing networks of community oncology practices, continues to strengthen its radiology, imaging and radiopharmaceutical therapy (RPT) program through strategic physician leadership, expanded clinical capabilities and ongoing investment in innovative cancer care that brings advanced treatments closer to where patients live and work.

The seasoned culinary leader will oversee menu strategy and innovation to support growth and drive guest engagement

The Magnificent Others Launched in 2025 and Over 2 Million Downloads and 76 Episodes to Date with Courtney Love, Billy Idol, Tom Morello and More

NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- Visiting Media and HotelPORT today announced a strategic partnership that will help hotels transform digital content from a static marketing asset into a measurable driver of commercial performance.

SCOTTSDALE, Ariz., July 23, 2026 (GLOBE NEWSWIRE) -- WillScot Holdings Corporation (“WillScot” or the “Company”) (Nasdaq: WSC), a leader in innovative temporary flexible space solutions, today announced that it will release its second quarter 2026 financial results on August 6, 2026, after market close.

Strengthened capital position supports continued advancement of NB1 clinical development, manufacturing readiness and intellectual property initiatives through Q2 2027

ROCHESTER, NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- Syntec Optics Holdings, Inc. (NASDAQ: OPTX) (“Syntec Optics”), a premier provider of deep tech solutions for defense and space modernization, today announced that it has been included in the Russell 3000® Index. The final, fully validated list of index members was implemented at the opening of the U.S. equity markets on Monday, June 29, 2026. The company is scheduled to receive education on the Russell indexes on July 24, 2026.

Fort Lee, NJ, July 23, 2026 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) (“Nuvectis” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of innovative therapies for the treatment of complement-related conditions and oncology, today announced that ciprocopan (NXP100), a once-daily oral complement Factor B inhibitor, received marketing approval from the National Medicinal Products Administration of China (NMPA) for the treatment of patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) previously untreated with Complement inhibitors (treatment naive).

SANTA CLARA, Calif., July 23, 2026 (GLOBE NEWSWIRE) -- Applied Materials, Inc. today announced that it will hold its fiscal third quarter 2026 earnings conference call on Thursday, Aug. 13, 2026, at 4:30 p.m. ET / 1:30 p.m. PT.

Leading pharmaceutical marketing executive joins leadership team to accelerate innovation and strengthen partnerships across the life sciences industry

Driven by FirstService Residential Division Organic Growth

The Short VersionWhen you invest in something, one of the first things you want to know is: if I need my money back, can I get it? Streamex built GLDY so that it can be bought or sold at any time, day or night, any day of the year. The sections below explain exactly how that works through GLDY’s multiple layers liquidity.

Recognition reflects Opti9’s continued growth, technical expertise, channel model and commitment to resilient customer outcomes

Grant Underscores CAU as a Leader in Environmental Politics and Sustainable Urban Planning

New spirits line brings the bold blood orange and honey profile of Revolver’s iconic Blood & Honey beer to Whiskey, Gin and Vodka launching exclusively in Texas

Second quarter 2026 Service revenue grew 19% compared to the second quarter 2025 and 8% compared to the first quarter 2026

*1.10 G/T AUEQ (0.98 G/T AU, 0.54 G/T AG, 0.07 % CU) OVER 103 M

Fast-acting, smoke-free ZONNA THC pouches deliver precise dosing in a discreet, portable pouch – expanding consumer choice through continued cannabis innovation

Net Sales were $216 million, an increase of 28%, driven by Vita Coco Coconut Water growth of 21%

FORT WORTH, Texas, July 23, 2026 (GLOBE NEWSWIRE) -- American Airlines Group Inc. (NASDAQ: AAL) today reported its second-quarter 2026 financial results, including record quarterly revenue, driven by strong demand for American’s product and solid commercial execution.

BOSTON, July 23, 2026 (GLOBE NEWSWIRE) -- ZoomRx, a strategic life sciences consultancy trusted by 100+ leading biopharma companies across the world, today announced the launch of Signal-IQ: Competitive Field Intelligence, a proprietary offering from its Decision Sciences practice that gives pharma commercial teams near-real-time, NPI-level visibility into how competitor sales forces are interacting with their HCP targets. This information can be used to drive timely counter-detailing and counter-messaging with integration into CRM systems for pre-call planning and fuel dynamic recommendations. It can also be used to improve promotional evaluation, forecasting, and targeting.

OPERATING PERFORMANCE ACCELERATESSEQUENTIAL LOAN GROWTH OF 5% AND CORE DEPOSIT GROWTH OF 8%, ANNUALIZEDNET INTEREST MARGIN WIDENS TO 3.42%TANGIBLE BOOK VALUE PER SHARE INCREASESCOMMON & PREFERRED DIVIDENDS PER SHARE DECLARED

NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- Valley National Bancorp (NASDAQ: VLY), the holding company for Valley National Bank, today reported net income for the second quarter 2026 of $170.9 million, or $0.29 per diluted common share, as compared to the first quarter 2026 net income of $163.9 million, or $0.28 per diluted common share, and net income of $133.2 million, or $0.22 per diluted common share, for the second quarter 2025. Excluding all non-core charges, our adjusted net income (a non-GAAP measure) was $172.8 million, or $0.30 per diluted common share, for the second quarter 2026, $168.9 million, or $0.29 per diluted common share, for the first quarter 2026, and $134.4 million, or $0.23 per diluted common share, for the second quarter 2025. See further details below, including a reconciliation of our non-GAAP adjusted net income, in the "Consolidated Financial Highlights" tables.

ZURICH, SWITZERLAND, July 23, 2026 (GLOBE NEWSWIRE) -- VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA”), an emerging leader in designing novel cancer therapies, today announced the appointment of Christoph Erkel, Ph.D., as Chief Scientific Officer (CSO), effective immediately. Christoph Erkel, previously Vice President of Research & Development at VERAXA, will apply his extensive management expertise in R&D to direct and accelerate development of the company’s proprietary BiTAC® (bi-targeted tumor-associated cytotoxicity) platform technologies, with the goal of developing safer and more effective cancer treatments for patients with solid tumors. He succeeds Rick Austin, Ph.D., who will be leaving the company after a successful transition period.

TORONTO, July 23, 2026 (GLOBE NEWSWIRE) -- illumin Holdings Inc. (TSX: ILLM, OTCQB: ILLMF) (“illumin” or “Company”), a leader in digital advertising technology that empowers marketers to make smarter decisions about communicating with online consumers, will report its second quarter 2026 financial results before market open on Thursday, August 6, 2026.

The brand’s award-winning THC margaritas will be available to festivalgoers 21+ across select bars throughout Grant Park during this year's festival

LONDON and NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and anterior segment eye diseases, today announced that OKYO Pharma’s Chief Executive Officer, Robert J. Dempsey, has purchased 15,000 of the Company’s ordinary shares on NASDAQ at $1.54 per share.

Formalizes the Strategic Investment and Commercial Framework Between the Companies Announced in April 2026

NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated financial markets for trading 12,000 U.S. and global securities, today announced the second quarter 2026 performance and quarterly rebalancing of the OTCQX® indexes, including the OTCQX Canada Index and the OTCQX Dividend Index.

SINGAPORE, July 23, 2026 (GLOBE NEWSWIRE) -- Aurora Mobile Limited (NASDAQ: JG) ("Aurora Mobile" or the "Company"), a leading provider of customer engagement and marketing technology services, announced enhancements to the customer service solution on GPTBots.ai, its enterprise-grade AI agent platform. GPTBots.ai Audio Agent now supports SIP connectivity via Twilio for integration with enterprise telephony infrastructure. LINE Customer Service Plugin 2.0 updates the agent workspace and adds notification capabilities for service teams.

TORONTO, July 23, 2026 (GLOBE NEWSWIRE) -- Osisko Gold Group Inc. (NYSE: OGG, TSXV: OGG) ("Osisko Gold" or the "Company") is pleased to announce final results and reconciliation analysis of its previously completed infill drilling program (the "Infill Program") in the Lowhee Zone of the Company's permitted, 100%-owned Cariboo Gold Project (the "Project"), located in central British Columbia, Canada.

Beam to Host Investor Webcast to Review BEAM-302 Clinical Data on Tuesday, September 8, 2026, at 7:00 a.m. ET

NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Nufarm Limited (ASX: NUF; OTCQX: NUFMF), a global crop protection and seed technologies company, has qualified to trade on the OTCQX® Best Market. Nufarm Limited upgraded to OTCQX from the Pink Limited™ Market.

Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com